2016
DOI: 10.1097/wco.0000000000000319
|View full text |Cite
|
Sign up to set email alerts
|

Multiple sclerosis

Abstract: Breakthroughs in the field of multiple sclerosis have led to a better understanding of the physiopathology of the disease, follow up, and treatment of the patients that develop relapsing remitting multiple sclerosis. The next challenge for multiple sclerosis will be to press forward to model and decipher multiple sclerosis progression, which will help both to develop therapeutics and generate knowledge about mechanisms of neurodegeneration.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
35
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 93 publications
(44 citation statements)
references
References 145 publications
(130 reference statements)
0
35
0
Order By: Relevance
“…Since spinal demyelination is a typical histopathological characteristic of MS patients (Frohman et al, 2006; Axisa and Hafler, 2016), we tested the correlation between clinical score of EAE and demyelination. And since onset-treatment with 600 mg/kg SHSST was more effective than was 300 mg/kg SHSST in inhibiting EAE symptoms ( Figures 3A,B and Table 2 ), we further studied use of that dosage (600 mg/kg).…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…Since spinal demyelination is a typical histopathological characteristic of MS patients (Frohman et al, 2006; Axisa and Hafler, 2016), we tested the correlation between clinical score of EAE and demyelination. And since onset-treatment with 600 mg/kg SHSST was more effective than was 300 mg/kg SHSST in inhibiting EAE symptoms ( Figures 3A,B and Table 2 ), we further studied use of that dosage (600 mg/kg).…”
Section: Resultsmentioning
confidence: 99%
“…Multiple sclerosis (MS) is a chronic and demyelinating inflammatory disorder of the central nervous system (CNS), which typically presents in adults who are 20 to 45 years of age (Frohman et al, 2006; Axisa and Hafler, 2016). Its typical neurologic symptoms are characterized as being quadriplegia, dyschezia, weakness, amblyopia, and ataxia (Frohman et al, 2006; Axisa and Hafler, 2016).…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…Because T cells mediate myelin degradation, MS is often referred to as an autoimmune disease (Piccio and Cross, 2011). Despite intense research, the cause of MS remains elusive, but the evidence accumulated so far points toward a multifactorial etiology, including genetic (Oksenberg, 2013; Cree, 2014; Sawcer et al, 2014; Axisa and Hafler, 2016) and environmental (O'Gorman et al, 2012; Ascherio, 2013; Malli et al, 2015) factors. In Caucasian cohorts, MHC haplotypes have been found strongly associated with MS (McFarland and Martin, 2007).…”
Section: Introductionmentioning
confidence: 99%